Summary of Product Characteristics
last updated on the eMC:
26/04/2007
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 26/04/2007 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 4.3 - Contraindications
-
Change to section 4.4 - Special warnings and precautions for Use
-
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
-
Change to section 4.8 - Undesirable Effects
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 12/2006 |
| Legal Category: POM |
| Black Triangle (CHM):
YES |
Free-text change information supplied by the pharmaceutical company
|
| Section 4.3, 4.4, 4.5, 4.8- changes due to BPI update
|
|
Updated on 24/09/2003 and displayed until 26/04/2007
|
Reasons for adding or updating:
|
-
Change to section 4.2 - Posology and Method of Administration
-
Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
|
|
Updated on 16/01/2003 and displayed until 24/09/2003
|
Reasons for adding or updating:
|
-
Transferred from eMC version 1
|
|
Updated on 16/07/2001 and displayed until 16/01/2003
|
Reasons for adding or updating:
|
-
Correction of spelling/typing errors
|
|
Updated on 12/07/2001 and displayed until 16/07/2001
|
Reasons for adding or updating:
|
-
Correction of spelling/typing errors
|
|
Updated on 06/09/1999 and displayed until 12/07/2001
|
Reasons for adding or updating:
|
|
|
|
